Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morabia, A.
Right arrow Articles by Costanza, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morabia, A.
Right arrow Articles by Costanza, M. C.
Related Collections
Right arrow Diabetes
Right arrow Other Chronic Disease
Right arrow Obesity, Overweight, Underweight
Right arrow Global Health
Right arrow Prevention
Right arrow Surveillance
Right arrow Cardiovascular Disease
The Obesity Epidemic as Harbinger of a Metabolic Disorder Epidemic: Trends in Overweight, Hypercholesterolemia, and Diabetes Treatment in Geneva, Switzerland, 1993–2003

Alfredo Morabia, MD, PhD and Michael C. Costanza, PhD

The authors are with the Division of Clinical Epidemiology, Geneva University Hospital, Geneva, Switzerland.



View larger version (28K):

[in a new window]
  		FIGURE 1—— Eleven-year trends (1993–2003, mean age-adjusted linear regression) in overweight (only), obesity, overweight and obesity combined, hypercholesterolemia, and diabetes treatment among a random sample of 6164 male residents of Geneva, Switzerland, aged 35 to 74 years.
Note. Overweight = 25 ≤ body mass index (BMI) < 30 kg/m2; obese = BMI ≥ 30 kg/m2; hypercholesterolemia = total plasma cholesterol ≥ 6.5 mmol/L (approximately 250 mg/dL) or self-report of taking medication for high cholesterol; diabetes treatment: self-reported.

 


View larger version (26K):

[in a new window]
  		FIGURE 2—— Eleven-year trends (1993–2003, mean age-adjusted linear regression) in overweight (only), obesity, overweight and obesity combined, hypercholesterolemia, and diabetes treatment among a random sample of 6107 female residents of Geneva, Switzerland, aged 35 to 74 years.
Note. Overweight = 25 ≤ body mass index (BMI) < 30 kg/m2; obese = BMI ≥ 30 kg/m2; hypercholesterolemia = total plasma cholesterol ≥ 6.5 mmol/L (approximately 250 mg/dL) or self-report of taking medication for high cholesterol; diabetes treatment: self-reported.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Public Health Association